HEPSANET paper on low cost biomarkers for fibrosis is published in Nature Communications

Written By Alexander Stockdale

Our collaborative paper on the use of low cost routinely available biomarkers for liver fibrosis in patients with chronic hepatitis B has been published in Nature Communications!

A blog which has been published alongside the article is here.

Alexander Stockdale
Previous

HEPSANET cohort profile paper published
Next

HEPSANET at the International Liver Congress 2022